NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 62 filers reported holding NEOGENOMICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $13,621,000 | +21.2% | 1,589,352 | +16.3% | 0.00% | 0.0% |
Q3 2016 | $11,236,000 | +3.4% | 1,366,920 | +1.1% | 0.00% | 0.0% |
Q2 2016 | $10,870,000 | +106.9% | 1,352,021 | +73.5% | 0.00% | +100.0% |
Q1 2016 | $5,253,000 | -11.2% | 779,314 | +3.6% | 0.00% | 0.0% |
Q4 2015 | $5,918,000 | +67.3% | 751,997 | +21.8% | 0.00% | 0.0% |
Q3 2015 | $3,538,000 | +41.6% | 617,411 | +33.7% | 0.00% | – |
Q2 2015 | $2,499,000 | +2476.3% | 461,848 | +2121.2% | 0.00% | – |
Q1 2015 | $97,000 | +870.0% | 20,793 | +754.3% | 0.00% | – |
Q4 2014 | $10,000 | -37.5% | 2,434 | -20.7% | 0.00% | – |
Q3 2014 | $16,000 | -98.5% | 3,071 | -99.0% | 0.00% | – |
Q1 2014 | $1,087,000 | -3.0% | 313,266 | +1.1% | 0.00% | – |
Q4 2013 | $1,121,000 | +13.5% | 309,727 | -6.0% | 0.00% | – |
Q3 2013 | $988,000 | -21.7% | 329,326 | +3.9% | 0.00% | – |
Q2 2013 | $1,262,000 | – | 316,961 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 1,291,019 | $22,477 | 12.11% |
Greenhouse Funds LLLP | 2,930,014 | $51,011,544 | 4.27% |
First Light Asset Management, LLC | 2,698,958 | $46,988,859 | 4.23% |
PERKINS CAPITAL MANAGEMENT INC | 197,000 | $3,430 | 3.23% |
Altium Capital Management LP | 240,000 | $4,178,400 | 2.32% |
FORMULA GROWTH LTD | 280,690 | $4,886,813 | 1.57% |
BOULDER HILL CAPITAL MANAGEMENT LP | 101,065 | $1,759,542 | 1.42% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,374,783 | $23,934,972 | 1.41% |
EMERALD ADVISERS, LLC | 1,669,324 | $29,062,931 | 1.39% |
Lisanti Capital Growth, LLC | 528,235 | $9,196,571 | 1.28% |